From: Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study
AML/MDSa | Malignant melanoma | Bladder cancer | Breast cancer | ||||
---|---|---|---|---|---|---|---|
Cases | Cases | Controls | Cases | Controls | Cases | Controls | |
N | 152 | 170 | 119 | 61 | 156 | 200 | 131 |
Median age (range) | 72 (22–95) | 66 (24–80) | 68 (22–96) | 69 (35–85) | 69 (21–90) | 59 (34–86) | 63 (23–85) |
Women/Men (%) | 73/79 (48/52) | 87/83 (51/49) | 53/66 (44.5/55.5) | 9/52 (15/85) | 34/122 (22/78) | 200/0 (100/0) | 131/0 (100/0) |